Insider · CIK 0002064987
Yixin Chen
Files at TVRD (Tvardi Therapeutics, Inc.). First filing -, latest -.
In brief
Yixin Chen files SEC Form 4 as officer at TVRD (Tvardi Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yixin Chen has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +7,213 | $0.00 | $0 | 7,213 | Apr 21, 2025 |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +14,752 | - | - | 14,752 | Apr 17, 2025 |
Questions about Yixin Chen
Answered from the filings on this page, as of the latest one.
Is Yixin Chen buying or selling?
Yixin Chen has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yixin Chen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yixin Chen has 0.
Where does Yixin Chen file Form 4?
Yixin Chen has filed Form 4 at TVRD (Tvardi Therapeutics, Inc.) as VP, Chem, Mfg and Ctrls. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.